Benzoyl Peroxide; Clindamycin Phosphate Patent Expiration
Benzoyl Peroxide; Clindamycin Phosphate was first introduced by Bausch Health Americas Inc
Benzoyl Peroxide; Clindamycin Phosphate Patents
Given below is the list of patents protecting Benzoyl Peroxide; Clindamycin Phosphate, along with the drug name that holds that patent and the company name owning that drug.
Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
---|---|---|---|---|
Acanya | US8288434 | Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent | Aug 05, 2029 | Bausch |
Onexton | US8288434 | Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent | Aug 05, 2029 | Bausch |
Acanya | US10220049 | Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent | Jun 03, 2029 | Bausch |
Acanya | US10624918 | Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent | Jun 03, 2029 | Bausch |
Acanya | US8663699 | Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent | Jun 03, 2029 | Bausch |
Acanya | US8895070 | Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent | Jun 03, 2029 | Bausch |
Acanya | US9078870 | Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent | Jun 03, 2029 | Bausch |
Onexton | US10137142 | Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent | Jun 03, 2029 | Bausch |
Onexton | US10220049 | Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent | Jun 03, 2029 | Bausch |
Onexton | US9504704 | Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent | Jun 03, 2029 | Bausch |
Onexton | US9561208 | Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent | Jun 03, 2029 | Bausch |
Acanya | US5733886 | Compositions of clindamycin and benzoyl peroxide for acne treatment |
Mar 31, 2015
(Expired) | Bausch |
Onexton | US5733886 | Compositions of clindamycin and benzoyl peroxide for acne treatment |
Mar 31, 2015
(Expired) | Bausch |
Duac | US5466446 | Topical compositions containing bensoyl peroxide and clindamycin and method of use thereof |
Feb 16, 2014
(Expired) | Stiefel |
Benzoyl Peroxide; Clindamycin Phosphate's Family Patents
Explore Our Curated Drug Screens
Benzoyl Peroxide; Clindamycin Phosphate Generic API Manufacturers
Several generic applications have been filed for Benzoyl Peroxide; Clindamycin Phosphate. The first generic version for Benzoyl Peroxide; Clindamycin Phosphate was by Mylan Pharmaceuticals Inc and was approved on Aug 11, 2009. And the latest generic version is by Padagis Israel Pharmaceuticals Ltd and was approved on Aug 20, 2024.
Given below is the list of companies who have filed for Benzoyl Peroxide; Clindamycin Phosphate generic, along with the locations of their manufacturing plants worldwide.
1. ACTAVIS LABS UT INC
Actavis Laboratories Ut Inc has filed for 1 generic for Benzoyl Peroxide; Clindamycin Phosphate. This 2.5%;eq 1.2% base version comes by the name CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE. Given below are the details of the strengths of this generic introduced by Actavis Labs Ut Inc.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
2.5%; EQ 1.2% BASE | gel | Prescription | TOPICAL | AB | Jun 19, 2015 |
2. CHARTWELL RX
Chartwell Rx Sciences Llc has filed for 1 generic for Benzoyl Peroxide; Clindamycin Phosphate. This 5%;1.2% version comes by the name CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE. Given below are the details of the strengths of this generic introduced by Chartwell Rx.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
5%; 1.2% | gel | Discontinued | TOPICAL | N/A | Aug 25, 2016 |
3. ENCUBE
Encube Ethicals Private Ltd has filed for 3 different strengths of generic version for Benzoyl Peroxide; Clindamycin Phosphate. All of these versions come by the name CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE. Given below are the details of the strengths of this generic introduced by Encube.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
5%; EQ 1% BASE | gel | Discontinued | TOPICAL | N/A | Jun 27, 2017 |
2.5%; EQ 1.2% BASE | gel | Discontinued | TOPICAL | N/A | Aug 19, 2019 |
5%; 1.2% | gel | Prescription | TOPICAL | AB | Apr 28, 2021 |
Manufacturing Plant Locations New
Encube's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Encube as present at those locations.
Country | City | Firm Name | ||||
---|---|---|---|---|---|---|
India |
|
4. GLENMARK SPECLT
Glenmark Specialty Sa has filed for 1 generic for Benzoyl Peroxide; Clindamycin Phosphate. This 5%;eq 1% base version comes by the name CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE. Given below are the details of the strengths of this generic introduced by Glenmark Speclt.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
5%; EQ 1% BASE
(reference standard) | gel | Prescription | TOPICAL | AB | Mar 14, 2019 |
5. MYLAN PHARMS INC
Mylan Pharmaceuticals Inc has filed for 1 generic for Benzoyl Peroxide; Clindamycin Phosphate. This 5%;eq 1% base version comes by the name CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE. Given below are the details of the strengths of this generic introduced by Mylan Pharms Inc.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
5%; EQ 1% BASE | gel | Prescription | TOPICAL | AB | Aug 11, 2009 |
6. PADAGIS ISRAEL
Padagis Israel Pharmaceuticals Ltd has filed for 4 different strengths of generic version for Benzoyl Peroxide; Clindamycin Phosphate. All of these versions come by the name CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE. Given below are the details of the strengths of this generic introduced by Padagis Israel.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
5%; 1.2%
(reference standard) | gel | Prescription | TOPICAL | AB | Jun 26, 2012 |
5%; EQ 1% BASE | gel | Prescription | TOPICAL | AB | Sep 21, 2015 |
2.5%; EQ 1.2% BASE | gel | Prescription | TOPICAL | AB | Sep 9, 2019 |
3.75%; EQ 1.2% BASE | gel | Prescription | TOPICAL | AB | Aug 20, 2024 |
Manufacturing Plant Locations New
Padagis Israel's manufacturing plants are situated in 1 country - Israel. Given below are the details of these plant locations as well as the firm names of Padagis Israel as present at those locations.
Country | City | Firm Name | ||
---|---|---|---|---|
Israel |
|
7. TARO
Taro Pharmaceuticals Inc has filed for 4 different strengths of generic version for Benzoyl Peroxide; Clindamycin Phosphate. All of these versions come by the name CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE. Given below are the details of the strengths of this generic introduced by Taro.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
5%; 1.2% | gel | Prescription | TOPICAL | AB | Dec 15, 2017 |
5%; EQ 1% BASE | gel | Prescription | TOPICAL | AB | May 25, 2018 |
3.75%; EQ 1.2% BASE | gel | Prescription | TOPICAL | AB | Jun 5, 2018 |
2.5%; EQ 1.2% BASE | gel | Prescription | TOPICAL | AB | Aug 19, 2019 |
Manufacturing Plant Locations New
Taro's manufacturing plants are situated in 3 countries - United States, Israel, Canada. Given below are the details of these plant locations as well as the firm names of Taro as present at those locations.
Country | City | Firm Name | ||||
---|---|---|---|---|---|---|
United States |
| |||||
Israel |
| |||||
Canada |
|
8. ZYDUS PHARMS
Zydus Pharmaceuticals Usa Inc has filed for 1 generic for Benzoyl Peroxide; Clindamycin Phosphate. This 5%;1.2% version comes by the name CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE. Given below are the details of the strengths of this generic introduced by Zydus Pharms.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
5%; 1.2% | gel | Prescription | TOPICAL | AB | Dec 28, 2018 |